Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...
Dr Reddy's Laboratories reported its consolidated Q3 results with a 2.5 per cent rise in profit to Rs 1,413.3 crore compared to Rs 1,378.9 crore in the same period last year ...